BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9868833)

  • 1. [The threat of premature labor: new aspects for management].
    Wertz JP; Frising M; Arendt J
    Bull Soc Sci Med Grand Duche Luxemb; 1998; 135(1):51-8. PubMed ID: 9868833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy.
    Richter ON; Dorn C; van de Vondel P; Ulrich U; Schmolling J
    Arch Gynecol Obstet; 2005 Jun; 272(1):26-30. PubMed ID: 15909190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of premature labor in sheep by a combined treatment of nimesulide, a prostaglandin synthase type 2 inhibitor, and atosiban, an oxytocin receptor antagonist.
    Grigsby PL; Poore KR; Hirst JJ; Jenkin G
    Am J Obstet Gynecol; 2000 Sep; 183(3):649-57. PubMed ID: 10992188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development and introduction of anti-oxytocic tocolytics.
    Lamont RF
    BJOG; 2003 Apr; 110 Suppl 20():108-12. PubMed ID: 12763125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
    Worldwide Atosiban versus Beta-agonists Study Group
    BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of atosiban and ritodrine in external cephalic version.
    Stergiotou I; Talbot F; Yoong W
    Acta Obstet Gynecol Scand; 2007; 86(8):927-9. PubMed ID: 17653876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice evaluation of atosiban in preterm labour management in six European countries.
    Fallon A; Fallon UB
    BJOG; 2007 Aug; 114(8):1043; author reply 1043-4. PubMed ID: 17635490
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
    Shennan A; Crawshaw S; Briley A; Hawken J; Seed P; Jones G; Poston L
    BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atosiban treatment for preterm labor--financial considerations and savings by implementing clinical guidelines].
    Hadar E; Mansur N; Ambar I; Hod M
    Harefuah; 2011 Jun; 150(6):502-6, 553. PubMed ID: 21800486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atosiban versus usual care for the management of preterm labor.
    Husslein P; Cabero Roura L; Dudenhausen JW; Helmer H; Frydman R; Rizzo N; Schneider D
    J Perinat Med; 2007; 35(4):305-13. PubMed ID: 17614750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection and premature labor.
    Ledger WJ
    Am J Perinatol; 1989 Apr; 6(2):234-6. PubMed ID: 2712921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No effect of tocolytic therapy with atosiban on maternal serum interleukin-6 and tumor necrosis factor-alpha in threatened preterm labor.
    Vitoratos N; Kountouris A; Makrakis E; Papadias K; Creatsas G
    J Matern Fetal Neonatal Med; 2007 Oct; 20(10):725-8. PubMed ID: 17763273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preterm labour. The present and future of tocolysis.
    Giles W; Bisits A
    Best Pract Res Clin Obstet Gynaecol; 2007 Oct; 21(5):857-68. PubMed ID: 17459777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers.
    Kim A; Shim JY
    BJOG; 2006 Dec; 113 Suppl 3():113-5. PubMed ID: 17206978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical practice evaluation of atosiban in preterm labour management in six European countries.
    Husslein P; Roura LC; Dudenhausen J; Helmer H; Frydman R; Rizzo N; Schneider D;
    BJOG; 2006 Dec; 113 Suppl 3():105-10. PubMed ID: 17206976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection in the prediction and antibiotics in the prevention of spontaneous preterm labour and preterm birth.
    Lamont RF; Sawant SR
    Minerva Ginecol; 2005 Aug; 57(4):423-33. PubMed ID: 16170287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women.
    Shim JY; Park YW; Yoon BH; Cho YK; Yang JH; Lee Y; Kim A
    BJOG; 2006 Nov; 113(11):1228-34. PubMed ID: 16978233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocolytic therapy and clinical experience. Combination therapy.
    Ingemarsson I
    BJOG; 2005 Mar; 112 Suppl 1():89-93. PubMed ID: 15715603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin receptor blockade: a new principle in the treatment of preterm labor?
    Andersen LF; Lyndrup J; Akerlund M; Melin P
    Am J Perinatol; 1989 Apr; 6(2):196-9. PubMed ID: 2540760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstetric and neonatal infection.
    Dinsmoor MJ
    Curr Opin Obstet Gynecol; 1991 Oct; 3(5):707-14. PubMed ID: 1958805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.